Liver disease

Researchers have identified the mechanism underlying the protective role zinc has in type 2 diabetes and the fatty liver disease associated with the condition. The findings open the door to developing a novel diabetes treatment.

In an exciting step forward in surgery advances, the first successful liver transplant performed by a robot has taken place in the US, offering minimal invasiveness and speedy recovery time. Clinics now plan to ramp up wider use of this innovative tech.

Researchers fed mice a probiotic designed to release an alcohol-metabolizing enzyme. Then they got them drunk. The results showed success in keeping the mice from getting too buzzed, and in helping them clear the alcohol from their systems faster.

Scientists have discovered that a specific class of immunity powerhouse T cells originate in the gut but venture around the body, patrolling for damaged sites and then assisting in repair, underpinning the importance of a healthy microbiome.

An impressive new study is pointing to a new kind of treatment to protect the vulnerable from COVID-19. The research revealed an old drug derived from bear bile and used for liver disease can block a crucial pathway used by SARS-CoV-2 to enter human cells.

A new experimental treatment could help treat end-stage liver disease – by growing tiny new livers elsewhere in the patient’s bodies. The technique, pioneered by cell therapy company LyGenesis, is due to begin human clinical trials within weeks.

New research has reported a link between elevated blood levels of perfluooctane sulfate (PFOS) and increased risk of liver cancer. The study is the first to directly associate exposure from this “forever chemical” to liver cancer in humans.

The liver can regenerate itself after taking damage, but whether that ability fades with age is unknown. A new study has found that age doesn’t slow down the liver’s regeneration, and whether you’re 20 or 80, your liver is on average just three years old.

Harvard scientists studying the molecular structure of cells under obesity-related stress have spotted alterations in the architecture that can be patched up, with "striking" results that restore them to healthy metabolic function.

Fatty liver disease is a condition linked to obesity and diabetes, and in turn often leads to further major complications. Researchers have now found a way to reverse the progression of the disease in mice, by quieting an overactive gene.

An impressive new study is presenting robust evidence showing the toxic proteins thought to be the cause of Alzheimer’s disease may be produced in the liver and travel through the blood before landing in the brain causing neuron damage.

Researchers believe they have found evidence indicating excess production of a neurotransmitter in the liver could be a causal factor in the onset of insulin resistance. The discovery points to preventative treatments for type 2 diabetes.